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INTRODUCTION
X-linked adrenoleukodystrophy (ALD) is an in­
herited disorder of peroxisomal (3-oxidation of sat­
urated very long chain fatty acids (VLCFA), and is 
characterized by progressive demyelination of the 
nervous system, and adrenocortical and gonadal 
insufficiency (Moser et aL, 1989). The most fre­
quent phenotypes are the rapidly progressive child­
hood cerebral ALD (CCALD) and the slowly 
progressive adrenomyeloneuropathy (AMN). Re­
cently, the ALD gene encoding a peroxisomal 
membrane associated protein (ALDP) was cloned
(Mosser et aL, 1993, 1994). The ALDP belongs to
the ATP-binding cassette (ABC) superfamily of 
transporter proteins, indicating that the primary 
defect in ALD interferes with a transport process 
essential for 3-oxidation of VLCFA. So far, few 
chromosomal deletions (Mosser et al., 1993; Car­
tier et al., 1993) and two exonic point mutations
(Cartier et alM 1993; Uchiyama et al., 1994) were
reported, and a possible hot spot for mutations was 
identified in the fifth exon of the ALD gene 
(Kemp et aL, 1994). We report two patients from 
two Dutch kindreds with mutations in introns of 
the ALD gene, leading to the use of novel or cryp­
tic 3 ' splice acceptor sites and prematurely termi­
nated proteins.
MATERIALS AND METHODS
In kindred ALD#1, a boy suffered from 
CCALD, and in kindred ALD# 19 a patient had 
AMN. The following primers, derived from the 
human ALD cDNA sequence (EMBL database 
No. Z21876), were used for amplification of 
cDNA, chromosomal DNA, and for sequencing:
ALD1880F: GG A AGGC AT G CAT CTGCTC;
ALD2061F: T ACCCGG ACT C AGT GG AG G A; 
ALD2114R: CAGGTCCTGCTCCGAGTAGC; 
ALD2204R: CGACAGGACGTCCTTCCAGT;
ALD2478R: GCTGCTT CT CCT CCGTC AG; 
and ALD2669R: TGTGATCCGAGCTTGGGG,
Three ALD specific intronic primers, derived 
from the genomic ALD sequence (Sarde et al.,
1994; Ligtenberg et al., 1995), were used to obtain
ALD-specific PCR products for genomic sequenc­
ing. ALD544F*: CAGGGGCCCTGTCGTCA- 
CAG (intron 7); ALD849F*: TGGAGGGTG- 
CACAGACTCTC (intron 8); and ALD1078R*: 
AGGCCACCTCCTCCCCTCAG (intron 9).
Total chromosomal DNA and mRNA were iso­
lated from fibroblasts, according to standard pro­
cedures. PCR and sequencing was performed as
described (Kemp et al., 1994; Ligtenberg et al., 
1995).
RESULTS AND DISCUSSION
In the CCALD patient from kindred ALD#1, 
a cDNA fragment generated with primers
ALD1880F (exon 6) and ALD2204R (exon 8) was
approximately 30-40 nucleotides shorter than 
control fragments (325 bp). By sequencing, we 
identified a deletion of the first 34 nucleotides of 
exon 7. Chromosomal DNA from this patient and 
his heterozygous mother was used to generate a 
PCR fragment containing the 336 bp intron 6 with
primers ALD1880F (exon 6) and ALD2U4R
(exon 7). Sequencing of these fragments revealed 
that the invariant A at position —2 of the ctttc-
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ccacag/GC splice acceptor site of exon 7 was mu­
tated into a G, creating ctttcccacgg/GC, which 
cannot function as a splice acceptor site. In the 
patients mother, both the normal and mutant al­
lele were present.
Exon 7 of the ALD gene contains a sequence 
CT CCCTGCGT G ACC A G/G, which serves as a
cryptic splice site. Splicing at this site creates an 
mRNA of which 34 bp are deleted, which leads to 
a frameshift at amino acid Arg 545, immediately 
followed by a stop codon. Electrophoresis of the 
patients PCR fragments, generated with primers
ALD1880F and ALD2204R, showed mainly the
291-bp fragment, but also a small amount of a 
shorter fragment corresponding to an mRNA in 
which exon 7 had been skipped (179 bp). Skipping 
of exon 7 also leads to a frameshift at amino acid 
Arg 545 and a stop codon 6 amino acids down­
stream.
In the AMN patient from kindred ALD#19, 
a cDNA fragment generated with primers
ALD2061F (exon 7) and ALD2669R (exon 10)
contained an insertion of 8 bp at the start of exon 
9. Sequencing of a chromosomal DNA fragment 
containing the 149-bp intron 8 revealed that the G 
at position —10 of the 3' splice acceptor site of 
exon 9 was substituted by an A, This mutation 
creates an upstream novel splice acceptor site 
(ctcggcccggacccccag/G into ctcggcccagACCCC- 
CAG/G). The insertion of the 8 bp leads to a 
frameshift at position Arg 622 and a premature 
stop codon 16 amino acids downstream. In this 
case only the cDNA fragment with the additional 
8 bp was found.
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